Annual CFF
$45.34 M
-$153.00 K-0.34%
December 1, 2024
Summary
- As of March 13, 2025, CCCC annual cash flow from financing activities is $45.34 million, with the most recent change of -$153.00 thousand (-0.34%) on December 1, 2024.
- During the last 3 years, CCCC annual CFF has fallen by -$126.06 million (-73.55%).
- CCCC annual CFF is now -87.01% below its all-time high of $348.93 million, reached on December 31, 2020.
Performance
CCCC Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$112.00 K
-$10.39 M-98.93%
December 31, 2024
Summary
- As of March 13, 2025, CCCC quarterly cash flow from financing activities is $112.00 thousand, with the most recent change of -$10.39 million (-98.93%) on December 31, 2024.
- Over the past year, CCCC quarterly CFF has dropped by -$10.39 million (-98.93%).
- CCCC quarterly CFF is now -99.94% below its all-time high of $194.05 million, reached on December 31, 2020.
Performance
CCCC Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$45.34 M
-$57.56 M-55.94%
December 31, 2024
Summary
- As of March 13, 2025, CCCC TTM cash flow from financing activities is $45.34 million, with the most recent change of -$57.56 million (-55.94%) on December 31, 2024.
- Over the past year, CCCC TTM CFF has dropped by -$57.56 million (-55.94%).
- CCCC TTM CFF is now -87.64% below its all-time high of $366.90 million, reached on June 30, 2021.
Performance
CCCC TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
CCCC Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.3% | -98.9% | -55.9% |
| 3 y3 years | -73.5% | -98.9% | -55.9% |
| 5 y5 years | +10000.0% | -98.9% | -55.9% |
CCCC Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -73.5% | +3852.6% | -99.8% | +101.0% | -73.7% | +473.6% |
| 5 y | 5-year | -87.0% | >+9999.0% | -99.9% | +101.0% | -87.6% | +473.6% |
| alltime | all time | -87.0% | >+9999.0% | -99.9% | +101.0% | -87.6% | +473.6% |
C4 Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | $112.00 K(-98.9%) | $45.34 M(-55.9%) |
| Dec 2024 | $45.34 M(-0.3%) | - | - |
| Sep 2024 | - | $10.51 M(+7682.2%) | $102.90 M(+26.0%) |
| Jun 2024 | - | $135.00 K(-99.6%) | $81.64 M(+1.1%) |
| Mar 2024 | - | $34.58 M(-40.0%) | $80.76 M(+77.5%) |
| Dec 2023 | $45.49 M(+3865.9%) | $57.67 M(-636.3%) | $45.49 M(-474.8%) |
| Sep 2023 | - | -$10.75 M(+1341.4%) | -$12.14 M(+1087.5%) |
| Jun 2023 | - | -$746.00 K(+9.1%) | -$1.02 M(+5911.8%) |
| Mar 2023 | - | -$684.00 K(-1555.3%) | -$17.00 K(-101.5%) |
| Dec 2022 | $1.15 M | $47.00 K(-87.0%) | $1.15 M(-26.8%) |
| Sep 2022 | - | $361.00 K(+39.4%) | $1.57 M(-12.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $259.00 K(-46.0%) | $1.79 M(-99.0%) |
| Mar 2022 | - | $480.00 K(+3.0%) | $172.03 M(+0.4%) |
| Dec 2021 | $171.40 M(-50.9%) | $466.00 K(-20.2%) | $171.40 M(-53.0%) |
| Sep 2021 | - | $584.00 K(-99.7%) | $364.99 M(-0.5%) |
| Jun 2021 | - | $170.50 M(<-9900.0%) | $366.90 M(+5.2%) |
| Mar 2021 | - | -$151.00 K(-100.1%) | $348.63 M(-0.1%) |
| Dec 2020 | $348.93 M(>+9900.0%) | $194.05 M(+7665.2%) | $348.93 M(+125.3%) |
| Sep 2020 | - | $2.50 M(-98.4%) | $154.88 M(+1.6%) |
| Jun 2020 | - | $152.22 M(>+9900.0%) | $152.38 M(>+9900.0%) |
| Mar 2020 | - | $156.00 K | $156.00 K |
| Dec 2019 | $244.00 K(-87.6%) | - | - |
| Dec 2018 | $1.96 M | - | - |
FAQ
- What is C4 Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for C4 Therapeutics?
- What is C4 Therapeutics annual CFF year-on-year change?
- What is C4 Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for C4 Therapeutics?
- What is C4 Therapeutics quarterly CFF year-on-year change?
- What is C4 Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for C4 Therapeutics?
- What is C4 Therapeutics TTM CFF year-on-year change?
What is C4 Therapeutics annual cash flow from financing activities?
The current annual CFF of CCCC is $45.34 M
What is the all time high annual CFF for C4 Therapeutics?
C4 Therapeutics all-time high annual cash flow from financing activities is $348.93 M
What is C4 Therapeutics annual CFF year-on-year change?
Over the past year, CCCC annual cash flow from financing activities has changed by -$153.00 K (-0.34%)
What is C4 Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of CCCC is $112.00 K
What is the all time high quarterly CFF for C4 Therapeutics?
C4 Therapeutics all-time high quarterly cash flow from financing activities is $194.05 M
What is C4 Therapeutics quarterly CFF year-on-year change?
Over the past year, CCCC quarterly cash flow from financing activities has changed by -$10.39 M (-98.93%)
What is C4 Therapeutics TTM cash flow from financing activities?
The current TTM CFF of CCCC is $45.34 M
What is the all time high TTM CFF for C4 Therapeutics?
C4 Therapeutics all-time high TTM cash flow from financing activities is $366.90 M
What is C4 Therapeutics TTM CFF year-on-year change?
Over the past year, CCCC TTM cash flow from financing activities has changed by -$57.56 M (-55.94%)